|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 202.66 USD | -11.88% |
|
-28.08% | +133.16% |
| 01/07 | Benchmark Adjusts Price Target on Dave to $320 From $229, Maintains Buy Rating | MT |
| 30/06 | Dave Inc.(NasdaqGM:DAVE) added to Russell 2000 Growth-Defensive Index | CI |
| Capitalization | 269.35Cr 230.32Cr 214.54Cr 199.54Cr 368.7Cr 23TCr 409.74Cr 2.57TCr 982.87Cr 11TCr 1.01TCr 989.39Cr 40TCr | P/E ratio 2025 * |
31.8x | P/E ratio 2026 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise value | 269.35Cr 230.32Cr 214.54Cr 199.54Cr 368.7Cr 23TCr 409.74Cr 2.57TCr 982.87Cr 11TCr 1.01TCr 989.39Cr 40TCr | EV / Sales 2025 * |
5.74x | EV / Sales 2026 * | 4.85x |
| Free-Float |
73.14% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Dave Inc.
More recommendations
More press releases
| Beursnieuweling Onward Medical boekt verlies | 26/22/26 | |
| Wall Street sluit hoger | 30/22/30 | |
| Wall Street op winst | 30/22/30 | |
| Wall Street richting hogere opening | 29/22/29 | |
| Futures voorspellen hogere opening Wall Street | 29/22/29 |
| 1 day | +4.27% | ||
| 1 week | -28.08% | ||
| Current month | -24.50% | ||
| 1 month | -2.68% | ||
| 3 months | +144.08% | ||
| 6 months | +147.54% | ||
| Current year | +133.16% |
| 1 week | 196.32 |  | 286.45 |
| 1 month | 186.2 | | 286.45 |
| Current year | 65.46 | | 286.45 |
| 1 year | 28.74 | | 286.45 |
| 3 years | 4.47 | | 286.45 |
| 5 years | 4.47 | | 491.07 |
| 10 years | 4.47 | | 491.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Wilk
CEO | Chief Executive Officer | 39 | 01/05/2016 |
Kyle Beilman
DFI | Director of Finance/CFO | 37 | 05/01/2022 |
Jessica Vaughan
COO | Chief Operating Officer | - | 01/03/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Jason Wilk
CHM | Chairman | 39 | 01/10/2015 |
Brendan Carroll
BRD | Director/Board Member | 47 | 05/01/2022 |
Dan Preston
BRD | Director/Board Member | 39 | 05/01/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.27% | -28.08% | +444.05% | +1,030.11% | 269.35Cr | ||
| +1.28% | -3.56% | +14.82% | +98.95% | 21TCr | ||
| +2.02% | +8.06% | +321.85% | +1,125.61% | 8.68TCr | ||
| -0.61% | -3.39% | +32.51% | +7.50% | 5.59TCr | ||
| +4.57% | -5.58% | - | - | 4.26TCr | ||
| +0.79% | -1.53% | +4.59% | -13.64% | 4.12TCr | ||
| -3.54% | +2.72% | +182.65% | +211.71% | 2.15TCr | ||
| -2.43% | +19.65% | +117.90% | +217.58% | 2.09TCr | ||
| -0.08% | -8.92% | +102.10% | +197.32% | 2.09TCr | ||
| -0.75% | -1.99% | -39.85% | +75.78% | 1.55TCr | ||
| Average | +0.53% | -1.84% | +131.18% | +327.88% | 5.17TCr | |
| Weighted average by Cap. | +0.94% | -0.90% | +88.88% | +285.52% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 47Cr 40Cr 37Cr 35Cr 64Cr 4.02TCr 71Cr 447.61Cr 171.14Cr 1.88TCr 175.9Cr 172.27Cr 6.91TCr | 56Cr 48Cr 44Cr 41Cr 76Cr 4.77TCr 85Cr 530.3Cr 202.75Cr 2.23TCr 208.39Cr 204.1Cr 8.19TCr |
| Net income | 9.31Cr 7.96Cr 7.41Cr 6.9Cr 13Cr 798.68Cr 14Cr 89Cr 34Cr 373.95Cr 35Cr 34Cr 1.37TCr | 12Cr 10Cr 9.5Cr 8.83Cr 16Cr 1.02TCr 18Cr 113.79Cr 44Cr 479.01Cr 45Cr 44Cr 1.76TCr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
274
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/25/11 | 202.66 $ | -11.88% | 9,76,970 |
| 10/25/10 | 229.98 $ | -6.13% | 6,05,302 |
| 09/25/09 | 244.99 $ | -6.52% | 5,89,354 |
| 08/25/08 | 262.07 $ | -6.34% | 5,40,936 |
End-of-day quote Nasdaq, July 11, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
202.66USD
Average target price
233.50USD
Spread / Average Target
+15.22%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DAVE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition